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   INTRODUCTION 
   IN VITRO TRANSACTIVATION OF PPARγ  
   IN SILICO DOCKING STUDIES 
Screening of food and medicinal plants for antidiabetic effects revealed that in particular extracts of carrot (Daucus carota) and purple 
coneflower (Echinacea purpurea) contain compounds with promising effects on type 2 diabetes (T2D) [1, 2]. A bioassay-guided fractionation 
approach resulted in the isolation of the polyacetylenes 1 and 2 from carrots [3] and the alkamides 35 from E. purpurea extracts (Fig. 1) [4, 
5]. All compounds are able to stimulate insulin-dependent glucose uptake (GU) and transactivate the nuclear receptor PPARγ in adipocytes 
in a dose-dependent manner, but to a different extent and show the characteristics of PPARγ partial agonists [3, 5]. 
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Fig. 1. Polyacetylenes (1 and 2) and alkamides (35) isolated by a bioassay-guided 
fractionation approach have demonstrated promising antidiabetic effects. 
Compoud Fold activation of PPARγa  
1 1.2  ± 0.5 [3] 
2 3.5  ± 1.5 [3] 
3/4 12  ± 1.3 [4] 
5 13  ± 2.4 [5] 
Table 1. Transactivation of PPARγ by 15 
Molecular docking studies of 15 revealed the characteristic binding modes of partial PPARγ agonists with a hydrogen bond to Ser342 (Fig. 
2). Compounds 15 also showed hydrophobic contacts but to different amino acids in the ligand binding domain of PPARγ, which can explain 
the differences in insulin-dependent GU and PPARγ activity observed for 15 (Table 1) [35]. The present results indicates that 15 may 
represent scaffolds for the development of partial PPARγ agonists for the treatment of T2D.  
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Fig. 2. Potential binding conformation of 1 and 2 in PPARγ (PDB code 2Q5S) in 2D and 3/4 in 3D. Blue brace/yellow spheres indicate 
lipophilic areas and red arrows indicate hydrogen bonds. 
aTransactivation of PPARγ by 15 (30 µM) 
relative to DMSO (vehicle). DMSO was set to 1 
and the results normalized to this. Rosi (1 µM) 
was the positive control. All values re expressed 
as mean ± SD of three independent experiments 
in triplicates. 
